임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
35건 표시
- 1상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
리드: 셀트리온
- 2상모집 중단 (진행 중)· ObeseStudy to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
- 1상모집 중단 (진행 중)· Healthy ParticipantsStudy to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
리드: 셀트리온
- 해당없음모집 중단 (진행 중)· Functional DyspepsiaThe Effect of Two Prokinetics in Patients With Functional Dyspepsia
협력: 대웅제약
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis
리드: 셀트리온
- 3상모집 중단 (진행 중)· Non Squamous Non Small Cell Lung CancerA Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
리드: 셀트리온
- 4상모집 중단 (진행 중)· Focal Onset SeizureOpen-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
리드: SK바이오팜
- 단계 미표기모집 중단 (진행 중)· Type 2 DiabetesEffect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Type 2 Diabetes MellitusRegistry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상모집 중단 (진행 중)· Non-small Cell Lung Cancer Stage IVA Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
리드: 삼성바이오에피스
- 1상모집 중단 (진행 중)· Non-small Cell Lung Cancer Stage IIA Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
리드: 삼성바이오에피스
- 3상모집 중단 (진행 중)· Tricuspid RegurgitationEnavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
협력: 대웅제약
- 4상모집 중단 (진행 중)· Essential HypertensionStudy to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
리드: 유한양행
- 단계 미표기모집 중단 (진행 중)· Diabetes Mellitus, Type 2To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus
리드: 대웅제약
- 4상모집 중단 (진행 중)· HypercholesterolemiaLong-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
리드: JW중외제약
- 단계 미표기모집 중단 (진행 중)· Hypertension, DyslipidemiaEvaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
리드: GC녹십자
- 단계 미표기모집 중단 (진행 중)· DyslipidemiasA Study to Evaluate the Efficacy and Safety of CREZET Tablet
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Rheumatoid ArthritisA Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
리드: 셀트리온
- 1상모집 중단 (진행 중)· Mucopolysaccharidosis IIA Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
리드: GC녹십자
- 2상모집 중단 (진행 중)· Idiopathic Pulmonary FibrosisClinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· DyslipidemiasEvaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· NSCLCKorean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
리드: 유한양행
- 단계 미표기모집 중단 (진행 중)· HypertensionReduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· HyperlipidemiasStudy to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
리드: 대웅제약
- 단계 미표기모집 중단 (진행 중)· Essential HypertensionStudy to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
리드: 유한양행
- 2상모집 중단 (진행 중)· Congenital HyperinsulinismHM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
리드: 한미약품
- 단계 미표기모집 중단 (진행 중)· Atrial FibrillationAtrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination
협력: 대웅제약
- 3상모집 중단 (진행 중)· Partial EpilepsySafety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
리드: SK바이오팜
- 4상모집 중단 (진행 중)· Kidney TransplantationStudy to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
리드: 종근당
- 3상모집 중단 (진행 중)· Primary Immune DeficiencyStudy of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
리드: GC녹십자
- 2상모집 중단 (진행 중)· NASH - Nonalcoholic SteatohepatitisStudy to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
리드: 한미약품
- 2상모집 중단 (진행 중)· Marginal Zone LymphomaCopanlisib and Rituximab in Marginal Zone Lymphoma Patients
협력: 셀트리온
- 3상모집 중단 (진행 중)· Rectal CancerConsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy
협력: JW중외제약
- 단계 미표기모집 중단 (진행 중)· Acute Myocardial Infarction (AMI)SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
협력: 종근당
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.